Intrinsic Value of S&P & Nasdaq Contact Us

Veeva Systems Inc. VEEV NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
83/100
6/7 Pass
SharesGrow Intrinsic Value
$303.33
+90.7%
Analyst Price Target
$280.10
+76.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Veeva Systems Inc. (VEEV) trades at a trailing P/E of 29.6, forward P/E of 18.0. Trailing earnings yield is 3.37%, forward earnings yield 5.57%. PEG 1.14. Graham Number is $73.91.

Criteria proven by this page:

  • VALUE (51/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 18.0 (down from trailing 29.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 1.14 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 3.37% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.57% as earnings recover.
  • Analyst consensus target $280.10 (+76.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 83/100 with 6/7 criteria passed.

SharesGrow 7-Criteria Score
83/100
SG Score
View full scorecard →
~
VALUE
51/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
80/100
→ Income
GROWTH
90/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — VEEV

Valuation Multiples
P/E (TTM)29.6
Forward P/E18.0
PEG Ratio1.14
Forward PEG0.29
P/B Ratio3.73
P/S Ratio8.43
EV/EBITDA26.8
Per Share Data
EPS (TTM)$5.53
Forward EPS (Est.)$8.86
Book Value / Share$43.90
Revenue / Share$19.44
FCF / Share$8.46
Yields & Fair Value
Earnings Yield3.37%
Forward Earnings Yield5.57%
Dividend Yield0.00%
Graham Number$73.91
SharesGrow IV$303.33 (+90.7%)
Analyst Target$280.10 (+76.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2017 79.9 3.27 9.49 11.39 -
2018 58.3 0.52 9.73 12.77 -
2019 68.4 1.45 12.71 18.25 -
2020 72.0 2.54 13.01 19.63 -
2021 112.2 4.77 18.81 29.09 -
2022 84.8 7.92 12.45 19.59 -
2023 54.3 4.33 7.13 12.30 -
2024 63.3 15.30 7.17 14.09 -
2025 52.9 1.52 6.47 13.75 -
2026 36.7 1.42 4.63 10.44 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $0.47 $544.04M $77.57M 14.3%
2018 $0.98 $685.57M $151.18M 22.1%
2019 $1.47 $862.21M $229.83M 26.7%
2020 $1.90 $1.1B $301.12M 27.3%
2021 $2.36 $1.47B $380M 25.9%
2022 $2.63 $1.85B $427.39M 23.1%
2023 $3.00 $2.16B $487.71M 22.6%
2024 $3.22 $2.36B $525.71M 22.2%
2025 $4.32 $2.75B $714.14M 26%
2026 $5.44 $3.2B $908.91M 28.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $7.94 $7.93 – $7.96 $3.17B $3.14B – $3.22B 19
2027 $8.86 $8.41 – $9.05 $3.6B $3.56B – $3.61B 19
2028 $9.89 $9.24 – $10.38 $4.04B $3.98B – $4.08B 16
2029 $11.15 $9.79 – $12.69 $4.54B $4.53B – $4.55B 5
2030 $13.17 $12.98 – $13.43 $5.17B $5.11B – $5.25B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message